Home / Stocks / TVTX

TVTX insider trading

Travere Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-04-16Baynes Roy D.
Director
Sold26,000$41.07$1.1M
2026-04-15REED ELIZABETH E
Chief Legal Officer and GC
Sold37,500$41.07$1.5M
2026-04-15Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold56,815$41.01$2.3M
2026-04-02Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold34,902$30.55$1.1M
2026-02-24Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold60,000$30.10$1.8M
2026-02-03Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold100,087$32.28$3.2M
2026-01-27Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold51,865$30.10$1.6M
2025-12-29ROTE WILLIAM E.
Chief Research Officer
Sold60,000$40.10$2.4M
2025-11-06Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
Sold67,115$36.00$2.4M
2025-10-30Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold92,872$30.38$2.8M
2025-02-04Dube Eric M
CHIEF EXECUTIVE OFFICER
Sold50,691$20.21$1.0M

See TVTX on the chart

Every insider buy and sell for TVTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.